Sort
39,280 grants matching “leukemia”
Systematic identification of hematopoietic stem cell expansion factors
$370,877Jiwang Zhang · Loyola University Chicago · R01 · FY2019 · HL
Systematic identification of hematopoietic stem cell expansion factors
$370,877Jiwang Zhang · Loyola University Chicago · R01 · FY2017 · HL
Systematic identification of hematopoietic stem cell expansion factors
$370,877Jiwang Zhang · Loyola University Chicago · R01 · FY2018 · HL
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
$370,870Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2022 · CA
A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines
$370,870Jonathan F Lovell · State University Of New York At Buffalo · R01 · FY2023 · CA
Ah Receptor Dysregulation Alters Hematopoietic Stem Cells
$370,868Thomas A Gasiewicz · University Of Rochester · R01 · FY2012 · ES
Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML
$370,810Hong-Yu Li · Univ Of Arkansas For Med Scis · R01 · FY2016 · CA
T Cell Targeting for GVHD
$370,809Bruce R. Blazar · University Of Minnesota · R01 · FY2009 · HL
Molecular and Cellular Biology of Thrombopoietin
$370,800Kenneth Kaushansky · University Of California, San Diego · R01 · FY2009 · DK
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2023 · CA
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$370,782Everett Stone · University Of Texas At Austin · R01 · FY2022 · CA
Regulation of HTLV-1 Transcription
$370,756Cynthia Masison · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers
$370,748Tan A. Ince · University Of Miami School Of Medicine · R33 · FY2019 · CA
Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes
$370,739Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Optimizing treatment decision by accounting for longitudinal biomarker trajectories and competing risks of each individual
$370,701Xuelin Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Intercellular transfer of prion in prion disease
$370,656Case Western Reserve University · R01 · FY2005 · NS
Mechanisms of KLF4 suppression in pediatric leukemia
$370,641H. Daniel Lacorazza · Baylor College Of Medicine · R01 · FY2018 · CA
Mechanisms of KLF4 suppression in pediatric leukemia
$370,641H. Daniel Lacorazza · Baylor College Of Medicine · R01 · FY2021 · CA
Mechanisms of KLF4 suppression in pediatric leukemia
$370,641H. Daniel Lacorazza · Baylor College Of Medicine · R01 · FY2020 · CA
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
$370,624Jing Zhang · University Of Wisconsin-Madison · R01 · FY2021 · CA
Roles of EAF2 in androgen action in the prostate
$370,620Zhou Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2014 · CA
T Cell Targeting for GVHD
$370,608Bruce R. Blazar · University Of Minnesota · R01 · FY2010 · HL
Dependency of AML on CARM1 activity
$370,596Stephen David Nimer · University Of Miami School Of Medicine · R01 · FY2024 · CA
GLYCOPROTEINS IN NORMAL &LEUKEMIC CELL DIFFERENTIATION
$370,591Burnham Institute For Medical Research · R01 · FY2001 · CA
Targeting Metabolic Liabilities of Leukemia-Initiating Cells
$370,575Jian Xu · Ut Southwestern Medical Center · R01 · FY2019 · CA